The FDA has given the Elon Musk company a green light for its second patient, the Wall Street Journal reports. Neuralink’s first implant in a human started to detach from that person’s brain, causing him to briefly lose some functions. To try to solve that problem, Neuralink reportedly plans to place the device’s threads deeper into the brain.
Justine Calma

Senior Science Reporter
Senior Science Reporter
More From Justine Calma
Wiley, a publishing company that’s more than 200 years old, is shuttering 19 journals today, the Wall Street Journal reports. Wiley has reportedly had to retract more than 11,300 papers recently “that appeared compromised” as generative AI makes it easier for paper mills to peddle fake research.


AI, EVs, and Joe Biden’s push for domestic manufacturing are putting more pressure on aging power grids. The nation also needs double the transmission capacity to meet Biden’s goal of 100 percent carbon pollution-free electricity.
To get more transmission lines up, FERC just overhauled rules for new projects — including a mandate that grid operators start anticipating energy needs at least 20 years in advance.
More residents across the US are asking that question about carbon dioxide, The Washington Post reports, as technologies that capture CO2 from smokestacks become more popular with companies that want to claim they’re fighting climate change. All that captured carbon dioxide has to go somewhere, and concerns are growing about the safety of new CO2 pipelines and underground storage wells.
[The Washington Post]









